This handout is for pediatric bronchiolitis. Your care team identified this based on: first wheezing episode in infant <2 yr after uri prodrome (aap 2014 ralston).
Other reasons your team may use this plan: increased work of breathing in infant — retractions, nasal flaring (aap 2014 ralston; nice 2021); apneic episode in infant with uri (aap 2014 ralston); poor feeding / dehydration during uri in infant (aap 2014 ralston; nice 2021).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| oxygen titrated to SpO2 ≥90% | NC 0.5-2 L/min titrated | inhaled | continuous | AAP 2014; HFNC for moderate-severe |
| normal saline maintenance fluids OR NG feeds | Holliday-Segar maintenance per kg | IV/NG | continuous | AAP 2014 supportive — IV vs NG per local practice; NG safe per Oakley 2013 |
| albuterol | 2.5 mg neb (0.15 mg/kg, min 2.5 mg, max 5 mg) | inhaled | one-time trial only — continue ONLY if clear improvement | AAP 2014: do NOT routinely; only continue if documented improvement on trial; otherwise stop |
| epinephrine | 0.5 mg neb (1:1000) | inhaled | single trial | Limited evidence; not standard; AAP 2014 against routine use |
| dexamethasone | 0.6 mg/kg PO/IV (max 16 mg) — NOT routine | PO/IV | NOT routine for bronchiolitis | AAP 2014 recommends against routine dexamethasone — Cochrane no benefit |
| hypertonic saline 3% nebulised | 4 mL nebulised | inhaled | q6-8 h | AAP 2014 weak recommendation in admitted only; recent meta-analyses mixed |
| palivizumab | 15 mg/kg IM monthly Nov-Apr (5 doses) | IM | monthly during RSV season | AAP 2014 — narrow eligibility; nirsevimab supersedes for many cohorts |
| nirsevimab | 50-100 mg IM (per weight band) | IM | single dose per RSV season | Hammitt MELODY NEJM 2022 + ACIP 2023 — universal infant prophylaxis |
Plan: Supportive care (AAP 2014 Ralston) — most clinical work is non-pharmacologic
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Pediatrician within 1-2 d post-discharge; RSV prevention plan next season (palivizumab high-risk OR nirsevimab universal — ACIP 2023; Hammitt MELODY NEJM 2022); asthma surveillance for recurrent (AAP 2014 Ralston)
Guideline: AAP 2014 Bronchiolitis CPG (Ralston) + PARIS HFNC NEJM 2018 + ACIP 2024 nirsevimab universal-infant + Hammitt MEDLEY NEJM 2022 + NICE NG9 2021